ABI-007
Term · Oncology and biomedicine · MLC-T-ONC-000104
A form of the anticancer drug paclitaxel that is used alone or with other drugs to treat certain types of breast cancer, non-small cell lung cancer, and pancreatic cancer. ABI-007 may have fewer side effects and work better than other forms of paclitaxel. It is also being studied in the treatment of other types of cancer. ABI-007 stops cancer cells from growing and dividing and may kill them. It is a type of taxane. Also called Abraxane, nanoparticle paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation, and protein-bound paclitaxel.
| Identifier | MLC-T-ONC-000104 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | Abraxane; nanoparticle paclitaxel; paclitaxel albumin-stabilized nanoparticle formulation; protein-bound paclitaxel |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000104",
"term": "ABI-007",
"field": "Oncology and biomedicine",
"definition": "A form of the anticancer drug paclitaxel that is used alone or with other drugs to treat certain types of breast cancer, non-small cell lung cancer, and pancreatic cancer. ABI-007 may have fewer side effects and work better than other forms of paclitaxel. It is also being studied in the treatment of other types of cancer. ABI-007 stops cancer cells from growing and dividing and may kill them. It is a type of taxane. Also called Abraxane, nanoparticle paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation, and protein-bound paclitaxel.",
"expansions": [
"Abraxane",
"nanoparticle paclitaxel",
"paclitaxel albumin-stabilized nanoparticle formulation",
"protein-bound paclitaxel"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/abi-007/"
}
Record 172 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.